Carrie Frame, DPM
Foot & Ankle Surgery · Charleston, WVNPI 1992904270
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (52.2%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Organogenesis Inc. accounts for 95.5% of it on its own, with 20 other manufacturers making up the rest. 2025 is the largest year on record at $26,242, 2.2 times the $11,992 reported in 2019. Among foot & ankle surgery clinicians in WV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 381 payments — averaging $259.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$95K
- Mid-atlantic Surgical Systems, LLC$2K
- Arthrex$807
- Amgen$471
- Smith+Nephew$355
- Paratek Pharmaceuticals, Inc.$264
- plus $1K from 15 others
What the payments were for
- Consulting fees$23,97524%
- Speaking & faculty fees$51,72452%
- Travel & lodging$15,05815%
- Food & beverage$8,2558%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 261 | $94,540 |
| Mid-atlantic Surgical Systems, LLC | 12 | $1,545 |
| Arthrex | 16 | $807 |
| Amgen(2 entities) | 23 | $471 |
| Smith+Nephew | 17 | $355 |
| Paratek Pharmaceuticals, Inc. | 13 | $264 |
| Tactile Systems Technology Inc | 5 | $185 |
| Vaporox, Inc. | 2 | $143 |
| AbbVie | 6 | $101 |
| Melinta Therapeutics, LLC | 7 | $100 |
| Comsort, Inc | 1 | $100 |
| Integra Lifesciences Corporation | 4 | $96 |
| Bioventus LLC | 5 | $92 |
| Angiodynamics, Inc. | 1 | $53 |
| Urgo Medical North America, LLC | 2 | $32 |
| Solventum Corporation | 1 | $29 |
| La Jolla Pharmaceutical Company | 1 | $26 |
| Vertex | 1 | $24 |
| DJO, LLC | 1 | $23 |
| Mallinckrodt Enterprises LLC | 1 | $20 |
| GRT US Holding, Inc. | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Apligraf$48,007
- Affinity$38,220
- NOVACHOR$37,102
- PURAPLY WOUND MATRIX$33,848
- PuraPly$25,983
- NuShield$22,037
- CYGNUS DUAL$16,215
- Puraply Antimicrobial$12,700
- Dermagraft$9,929
- Puraply/Affinity/NuTech$9,929
- KRYSTEXXA$140
- VHT-200 Wound Treatment System$122
- Flexitouch Plus$107
- Entre Plus$107
- SIVEXTRO$100
How this compares
$99,012 in reported general payments places this provider in the 95th percentile of 36 foot & ankle surgery providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NuzyraOmadacycline Tosylate | 20 | $155,187 |
| Daptomycin | 38 | $34,058 |
| ErtapenemErtapenem Sodium | 17 | $12,857 |
| Linezolid | 15 | $8,310 |
| Piperacillin-TazobactamPiperacillin Sodium/Tazobactam | 13 | $4,077 |
| Doxycycline Monohydrate | 19 | $641 |
| Doxycycline Hyclate | 38 | $577 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 85 | $568 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 31 | $388 |
| Gabapentin | 37 | $341 |
| Levofloxacin | 26 | $230 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 16 | $124 |
| Ondansetron OdtOndansetron | 21 | $76 |
| Ondansetron Hcl | 13 | $39 |
| Oxycodone Hcl | 12 | $35 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Paratek Pharmaceuticals, Inc.Nuzyra | $264 | $155,18720 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 36 foot & ankle surgery providers in West Virginia.
Other foot & ankle surgery in Charleston
- Mohammad ImaniCharleston$5K
- Michael GentileHuntington$103K
- Kevin BrownHuntington$31K
- Jana AtikParkersburg$17K
- Kristin SilinskiParkersburg$16K
- Bradley HoffmanPrinceton$14K
- James PipesRipley$12K
- Chinenye EzikeBeckley$11K
- James ReaganHuntington$11K
- Crystal Dawn BradshawWheeling$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.